EFTA00460655.pdf

From: Lesley Groff To: Peter Attia Cc: Jesse < , Peter Attia < Subject: Re: Meeting with JE Date: Tue, 17 Oct 2017 17:00:12 +0000 good for us also...anytime in between there...May On Oct 17, 2017, at 12:58 PM, Peter Attia < I can make it work between 12 and 4 > wrote: Peter Attia, M.D. I Attia Medical, PC The information contained in this transmission may contain privileged and confidential information, including patient information protected by federal and state privacy laws. It is intended only for the use of the person(s) named above. If you are not the intended recipient, you are hereby notified that any review, dissemination, distribution, or duplication of this communication is strictly prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message From: Lesley Groff [mailto: Sent: Tuesday, October 17, 2017 9:58 AM To: Jesse Cc: Mary Stephens Subject: Re: Meeting with JE Would Monday Oct. 30th work for everyone? Jeffrey will be in NY... On Oct 17, 2017, at 10:33 AM, Jesse Schwartzman < wrote: Sounds good. Happy to touch base with you Peter about JE, and then problem solve the leg issue together. ; Peter Attia < On Oct 17, 2017, at 10:27 AM, Mary Stephens e > wrote: Thanks Peter. Jesse - I will work with Lesley on JE's schedule then will circle back with you. Best, M. Mary Stephens I Attia Medical, PC I Director of Business Administration I From: Peter Attia Sent: Tuesday, October 17, 2017 7:26 AM To: Lesley Groff >; Mary Stephens < ; Jesse Schwartzman Subject: Meeting with JE EFTA00460655 Lesley, Mary — I spoke with JE this morning about his legs and I want to propose that Jesse and I meet with him for an hour when we are all in NY. I want to put him through a set of exercises to try to diagnose the problem. (Jesse, I have some ideas I'd like to run by you before we see JE). Thanks much, P Peter Attia, M.D. I Attia Medical, PC I (m) The information contained in this transmission may contain privileged and confidential information, including patient information protected by federal and state privacy laws. It is intended only for the use of the person(s) named above. If you are not the intended recipient, you are hereby notified that any review, dissemination, distribution, or duplication of this communication is strictly prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message EFTA00460656